Literature DB >> 2327923

Vascular complications following orthotopic liver transplantation.

R Bell1, A G Sheil, J F Thompson, M S Stephen, A A Eyers, A Shun, R C Waugh.   

Abstract

During the first 3 years of the Australian National Liver Transplantation Programme, 51 liver grafts were performed in 46 patients. There were 11 major vascular complications encountered following 10 liver transplants in eight (17%) patients. They caused death in three patients and the need for retransplantation in two others. Hepatic artery thrombosis (HAT) occurred five (10%) times, producing a spectrum of clinical illness ranging from death to an asymptomatic event. Other vascular complications included hepatic artery stenosis not complicated by thrombosis (two), primary (one) and secondary (one) haemorrhage, thrombosis of a mesoportal venous graft (one) and inferior vena caval stenosis (one). Vascular complications are a significant cause of morbidity and mortality following liver transplantation. Predisposing and precipitating factors should be recognized and minimized.

Entities:  

Mesh:

Year:  1990        PMID: 2327923

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  3 in total

1.  Urgent revascularization of liver allografts after early hepatic artery thrombosis.

Authors:  A D Pinna; C V Smith; H Furukawa; T E Starzl; J J Fung
Journal:  Transplantation       Date:  1996-12-15       Impact factor: 4.939

2.  Feasibility and effectiveness of a new algorithm in preventing hepatic artery thrombosis after liver transplantation.

Authors:  Sascha A Müller; Bruno M Schmied; Arianeb Mehrabi; Thilo Welsch; Peter Schemmer; Ulf Hinz; Jürgen Weitz; Jens Werner; Markus W Büchler; Jan Schmidt
Journal:  J Gastrointest Surg       Date:  2008-11-26       Impact factor: 3.452

3.  Causes of arterial bleeding after living donor liver transplantation and the results of transcatheter arterial embolization.

Authors:  Jeong Ho Kim; Gi-Young Ko; Hyun-Ki Yoon; Ho-Young Song; Sung-Gyu Lee; Kyu-Bo Sung
Journal:  Korean J Radiol       Date:  2004 Jul-Sep       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.